EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Framework-Dependent Classification and Long-Term Outcomes of Historical NIFTP: A Slide Re-Review with Follicular-Variant Papillary Thyroid Carcinoma Comparators

Buket Yılmaz Bulbul, Nuray Can, Nuri Isler, Burak Andac, Esra Zeynep Yucesan, Buse Ekici, Isil Yigitbasi, Seda Dogan, Gamze Nur Aktas, Mehmet Celik

Journal of Clinical Medicine · 2026-11-12 · 15 (22) · 8868

DOI: 10.3390/jcm15228868 ↗
AbstractBibliografische Angaben

Abstract

Background/Objectives: Diagnostic criteria for non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) have changed twice since 2016, most visibly in the tolerance for true papillae and in the role of molecular findings. We evaluated historical NIFTPs under the original and subsequent frameworks and related framework-specific classification to long-term outcomes. Methods: In this single-center, retrospective cohort (surgery 2007–2016), archival slides of 79 historical NIFTPs with linked longitudinal follow-up were independently re-reviewed in 2026 by two pathologists without knowledge of long-term outcomes or molecular results; their framework-specific classifications were concordant in all cases. Reasons for failure to retain the diagnosis across all frameworks were classified as criterion-dependent, criterion-independent, or technical. Outcomes were compared with 56 infiltrative and 39 invasive encapsulated follicular-variant papillary thyroid carcinomas (FVPTCs) from the same institution. Results: Thirty-six tumors (45.6%; 95% CI, 34.3–57.2%) qualified as NIFTP under all frameworks. Retention was 47/79 (59.5%; 95% CI, 47.9–70.4%) under the original 2016 criteria, 37/79 (46.8%; 95% CI, 35.5–58.4%) under the 2018 consensus primary criteria, and 46/79 (58.2%; 95% CI, 46.6–69.2%) under WHO 2022. Ten tumors with well-formed true papillae occupying

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →